Analysis of the genetic background associated with sporadic periodic paralysis in Japanese patients

J Neurol Sci. 2020 May 15:412:116795. doi: 10.1016/j.jns.2020.116795. Epub 2020 Mar 24.

Abstract

Periodic paralysis (PP) is a rare disease caused by abnormal excitability of the sarcolemma, resulting in the episodic weakness in extremities. Two major subtypes have been identified: primary/familial PP showing Mendelian inheritance of a mutation in the ion channel genes expressed in skeletal muscle, and secondary/sporadic PP which does not show Mendelian inheritance. Thyrotoxic periodic paralysis (TPP) contributes to the majority of secondary PP cases in Asians and Latin Americans, suggesting that genetic factors may underlie the pathogenesis. In contrast, sporadic periodic paralysis (SPP) has no familial history and no secondary factors. The genetic features associated with SPP in Japanese patients remain unexplored. Here, we investigate whether nine single nucleotide variants (SNVs), rs623011, rs312691, rs393743, rs312692, rs312736, rs992072, rs312732, rs723498, and rs312707, found in TPP and/or SPP in other Asian populations are also associated with Japanese SPP cases. The study cohort included 43 Japanese periodic paralysis patients with no mutations in causative genes (SCN4A, CACNA1S, and KCNJ2), no myotonia, and with euthyroid function. The results showed disease susceptibility for all nine SNVs in our Japanese SPP cohort. One of them, rs312691, was newly confirmed to show susceptibility to SPP. Our results suggest the genetic background underlies periodic paralysis.

Keywords: Hypokalemic periodic paralysis; Single nucleotide polymorphism: Sanger sequencing; Sporadic periodic paralysis.

MeSH terms

  • Asian People / genetics
  • Genetic Background
  • Humans
  • Hypokalemic Periodic Paralysis* / genetics
  • Japan
  • NAV1.4 Voltage-Gated Sodium Channel
  • Paralysis

Substances

  • NAV1.4 Voltage-Gated Sodium Channel
  • SCN4A protein, human